News
Stay up to date on the latest crypto trends with our expert, in-depth coverage.

1Bitget UEX Daily | US Plans to Implement 15% Global Tariffs This Week; Trump Nominates Walsh as Fed Chair; BlackRock Continues to Increase Bitcoin Holdings Recently (March 05, 2026)2Broadcom FY2026 Q1 Earnings: AI Revenue Doubles, Record Results, Strong Guidance, $10B Buyback3Broadcom CEO Predicts AI Chip Revenue Will Surpass $100 Billion by 2027
Flash
21:03
Johnson & Johnson announced that its Tecvayli® combined with Darzalex Faspro® treatment regimen has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of relapsed or refractory multiple myeloma patients.This approval is significant because it provides patients with a potentially new standard of care, which can even be used early in the second-line treatment stage of the disease.
20:36
U.S. federal banking regulators clarify capital treatment rules for tokenized securitiesThe U.S. federal banking regulators jointly issued a FAQ clarifying the capital treatment rules for tokenized securities. Tokenized securities refer to securities whose ownership is represented using distributed ledger technology. The FAQ states that eligible tokenized securities generally receive the same capital treatment under capital rules as their non-tokenized counterparts. Regulators emphasize that capital rules remain technologically neutral, and the technology used for issuing and trading securities usually does not affect capital treatment. Banks holding tokenized securities must follow risk management practices and comply with relevant laws and regulations.
20:02
Tevogen Bio Holdings (Tevogen) has recently taken a key step in its generic drug business strategy, signing a letter of intent to officially begin evaluating the potential acquisition of Apozeal Pharmaceuticals.This move marks Tevogen's accelerated expansion of its generic drug product line to strengthen its market competitiveness in the biopharmaceutical sector. Through this strategic assessment, Tevogen is expected to further integrate industry resources and increase its share in the global generic drug market.
News